Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue Xenografts

• Patrick C. Hermann,

  Affiliation Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Sara M. Trabulo,

  Affiliation Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Bruno Sainz Jr,

  Affiliation Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Anamaria Balic,

  Affiliation Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Elena Garcia,

  Affiliation Gastrointestinal Cancer Clinical Research Unit, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Stephan A. Hahn,

  Affiliation Department of Molecular GI-Oncology, Ruhr-University Bochum, Bochum, Germany

  ⨯
• Mallaredy Vandana,

  Affiliation Nanomedicine Laboratory, Institute of Life Sciences, Bhubaneswar, India

  ⨯
• Sanjeeb K. Sahoo,

  Affiliation Nanomedicine Laboratory, Institute of Life Sciences, Bhubaneswar, India

  ⨯
• Patrizia Tunici,

  Affiliation Department of Oncology, Siena Biotech S.p.A., Siena, Italy

  ⨯
• Annette Bakker,

  Affiliation Children’s Tumor Foundation, New York, New York, United States of America

  ⨯
• Manuel Hidalgo,

  Affiliation Gastrointestinal Cancer Clinical Research Unit, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯
• Christopher Heeschen

  * E-mail: cheeschen@cnio.es

  Affiliation Stem Cells and Cancer Group, Clinical Research Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

  ⨯